Physician profile
Kenneth A James
NPI 1497782213
$2,476.19
in general payments reported to CMS, 2019-2025
25 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $148 · 2021: $541 · 2022: $600 · 2023: $128 · 2024: $272 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $668.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $418.98 | 2019-2025 | |
| Abbvie INC. | $269.77 | 2020-2022 | |
| Avion Pharmaceuticals | $257.68 | 2019-2022 | |
| Pfizer INC. | $232.02 | 2019-2024 | |
| Therapeuticsmd, INC. | $197.84 | 2019-2021 | |
| Lupin INC. | $170.24 | 2019-2020 | |
| Ethicon US, LLC | $117.23 | 2021 | |
| Minerva Surgical, INC | $116.63 | 2019-2024 | |
| Evofem Biosciences, INC. | $78.34 | 2021-2022 | |
| Exeltis, USA INC. | $75.26 | 2020-2024 | Slynd |
| Hologic Sales and Service, LLC | $74.63 | 2019-2024 | Aptima, Acessa Provu System |
| Organon LLC | $74.02 | 2022 | |
| Shield Therapeutics INC | $66.37 | 2022 | |
| Coopersurgical, INC. | $52.74 | 2022-2023 | Summit Doppler |
| Bayer Healthcare Pharmaceuticals INC. | $48.75 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $37.72 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $37.44 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $24.89 | 2023 | Veozah |
| Aspira Women'S Health INC | $22.21 | 2024 | Ova1 |
| Olympus America INC. | $20.04 | 2022 | |
| Myovant Sciences INC. | $20.03 | 2021 | |
| Duchesnay USA Incorporated | $19.83 | 2019 | |
| Channel Medsystems, INC. | $19.33 | 2022 | |
| Allergan, INC. | $12.99 | 2019 | |
| Meditrina | $11.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.